Canton Strategic Holdings (CNTN) Change in Account Payables (2021 - 2026)
Canton Strategic Holdings (CNTN) reported Change in Account Payables of -$687963.0 for Q1 2026, down 1191.95% on a YoY basis from $63003.0 in Q1 2025, and down 303.3% quarter-over-quarter from $338404.0 in Q4 2025.
Canton Strategic Holdings (CNTN) Change in Account Payables (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Change in Account Payables for 6 years, with the latest figure at -$687963.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 1191.95% year-over-year to -$687963.0; the trailing twelve-month figure through Mar 2026 stood at -$528489.0 (down 431.5% YoY), and the FY2025 full-year result was $222477.0, up 22.86% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$687963.0, down from $338404.0 in the prior quarter.
- The five-year high for Change in Account Payables was $466532.0 in Q2 2023, with the low at -$687963.0 in Q1 2026.
- Historically, Change in Account Payables has averaged -$27735.0 across 5 years, with a median of -$1720.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 1330.11% — and 2025, when it sank 1363.97%.
- Canton Strategic Holdings' Change in Account Payables stood at $58830.0 in 2022, then sank by 491.16% to -$230118.0 in 2023, then soared by 232.9% to $305827.0 in 2024, then gained by 10.65% to $338404.0 in 2025, then slumped by 303.3% to -$687963.0 in 2026.
- The last three Change in Account Payables figures came in at -$687963.0 (Q1 2026), $338404.0 (Q4 2025), and -$111356.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -687,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687,963.00 |
| Mar 31, 2026 | -687,963.00 |
| Dec 31, 2025 | 338,404.00 |
| Dec 31, 2025 | 338,404.00 |
| Sep 30, 2025 | -111,356.00 |
| Sep 30, 2025 | -111,356.00 |
| Jun 30, 2025 | -67,574.00 |
| Jun 30, 2025 | -67,574.00 |
| Mar 31, 2025 | 63,003.00 |
| Mar 31, 2025 | 63,003.00 |
| Dec 31, 2024 | 305,827.00 |
| Dec 31, 2024 | 305,827.00 |
| Sep 30, 2024 | 8,810.00 |
| Sep 30, 2024 | 8,810.00 |
| Jun 30, 2024 | -218,215.00 |
| Jun 30, 2024 | -218,215.00 |
| Mar 31, 2024 | 84,667.00 |
| Mar 31, 2024 | 84,667.00 |
| Dec 31, 2023 | -230,118.00 |
| Dec 31, 2023 | -230,118.00 |